Article
CYP2E1 and NQO1 genotypes, smoking and bladder cancer.
Pharmacogenetics - 1 Jun 2003
Choi Ji-Yeob, Lee Kyoung-Mu, Cho Soo-Hun, Kim Soo-Woong, Choi Han-Yong, Lee Sang-Yoon, Im Hyoung-June, Yoon Ki Jung, Choi Hwang, Choi Inmi, Hirvonen Ari, Hayes Richard B, Kang Daehee
Abstract excerpt
BACKGROUND: Cytochrome P450 2E1 (CYP2E1) and NAD(P)H:quinone oxidoreductase (NQO1) catalyze the activation of some environmental procarcinogens present in tobacco smoke (i.e. nitrosoamines and heterocyclic amines). We conducted a hospital based case-control study to evaluate the potential association between genetic polymorphisms of CYP2E1 (C1019T in the 5' flanking region) and NQO1 (C609T in exon 6) and bladder...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
